BPC-157 + TB-500 Pen

Description

BPC-157 + TB-500 20mg: Pre-Formulated Research Pen

A pre-combined research blend of BPC-157, a 15-amino-acid gastric peptide sequence, and TB-500, a thymosin beta-4 derived peptide, supplied as a 20mg total pre-formulated solution in a sealed 3 mL research pen for laboratory research. The two address overlapping but mechanistically distinct pathways: BPC-157 studied for nitric oxide system modulation and angiogenic signaling, TB-500 for actin sequestration and cell migration. Synthesized in the United States and supplied in solution, with no reconstitution step.

• Strength: 20mg total per pen
• Format: Pre-formulated solution, sealed 3 mL pen
• Purity specification: ≥98%, each component
• Origin: U.S. synthesized

Trust signals

• U.S. synthesized research material, supplied ready to use
• Tracked shipping with delivery confirmation

Handling

Store the sealed pen refrigerated at 2 to 8°C, protected from light. Supplied in solution: no reconstitution and no added solvent. Avoid freeze-thaw cycling. Return to refrigeration between uses.

For verified compound data on each component, see our BPC-157 research overview and TB-500 research overview.

For research use only. Not for human or veterinary use. Not approved by the FDA. 21+